WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 23-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 13'7301 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 24'8821 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 38'612  38'620  38'619  38'609  38'594  38'486  38'195  35'783 
Births 387  393  399  404  408  372  571  699 
Surviving infants 385  392  398  402  406  368  561  684 
Pop. less than 5 years 1'994  2'028  2'070  2'100  2'088  1'998  2'978  3'245 
Pop. less than 15 years 5'771  5'748  5'746  5'761  5'774  7'492  9'623  8'612 
Female 15-49 years 9'231  9'294  9'350  9'403  9'466  10'127  9'415  9'223 

Number of reported cases

(Click for retrospective incidence data for Poland)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  84  71  77  56'471  24'882 
Mumps
ChartChart
  2'436  2'779  17'548 
Pertussis
ChartChart
  2'183  4'682  2'269  292  232 
Polio*
ChartChart
 
Rubella
ChartChart
  38'546  6'263  46'181 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  14  19  14  65  89 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Poland)
Vaccine year result method % card seen                                                
BCG          93  94  96  97  93 
DTP1         
DTP3          99  99  98  96  96 
DTP4         
IPV1         
HepB_BD          95 
HepB3          96  97  99 
Hib3          99  99 
JapEnc         
MCV1          98  98  97  95  92 
MCV2          93  95  96 
PCV1         
PCV3         
Pol3          95  95  98  96  96 
Rota1         
RotaC         
Rubella1          98  98 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Poland)
BCG
ChartChart
  93  93  94  94  96  97  93 
DTP1
ChartChart
  99  99  99  99  99  98  98 
DTP3
ChartChart
  99  99  99  99  98  96  96 
HepB3
ChartChart
  96  96  97  98  99 
HepB_BD
ChartChart
  93  93  93  93  95 
Hib3
ChartChart
  99  99  99  99 
MCV1
ChartChart
  98  98  98  98  97  95  92 
MCV2
ChartChart
  93  93  95  95  96 
PCV3
ChartChart
 
Pol3
ChartChart
  95  95  95  96  98  96  96 
RotaC
ChartChart
 

Number of districts in the country 344  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 7-8 weeks; 3-4, 5-6, 16-18 months; Yes
HepB birth; 2, 7 months; Yes
Hib 2, 3-4, 5-6, 16-18 months; Yes
IPV 3-4, 5-6, 16-18 months; Yes
MMR 13-14 months; 10 years; Yes
OPV 6 years; Yes
Td 14, 19 years; Yes
TdaP 6 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR   No  No    No  No   
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number         320     

System performance

Total Nº districts in country number   344  379    379  379   
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND         No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR     Yes    Yes  Yes   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%         100     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR   Yes  Yes    No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.